Access to Investigational Drugs

Access to investigational drugs allows patients with serious or life-threatening conditions to receive treatments still under clinical testing, before they are officially approved. This access is granted through special programs like expanded access or compassionate use, which require safeguards to ensure patient safety while providing potentially beneficial therapies. While these drugs are not yet fully authorized, they are obtained with medical supervision and informed consent, offering hope for those with limited options when no approved treatments are effective.